Literature DB >> 9002382

Hypercholesterolemia and the progression of the renal dysfunction in chronic renal failure patients.

M Washio1, S Okuda, M Ikeda, H Hirakata, F Nanishi, K Onoyama, T Yoshimura, M Fujishima.   

Abstract

The effect of hyperlipidemia on the progression of chronic renal failure was investigated in 104 chronic renal failure patients, aged 39.3 +/- 2.9 years. The follow up period was 4.1 +/- 2.9 years. The serum creatinine level was 2.1 +/- 1.1 (mean +/- SD) mg/dl at the beginning of study and increased to 8.7 +/- 4.4 mg/dl at the end of the study. The reciprocal serum creatinine concentration (1/Cr) was plotted against the observation time, and the slope was calculated. The absolute value of the slope was used as the progression rate of renal impairment. The progression rate was positively related to total cholesterol level or urinary protein score, while it was negatively related to total protein level. Without the influence of urinary protein score, the progression rate correlated with total cholesterol level. The result suggests that hypercholesterolemia may be an independent aggravating factor in the progression of renal dysfunction in chronic renal failure patients.

Entities:  

Mesh:

Year:  1996        PMID: 9002382     DOI: 10.2188/jea.6.172

Source DB:  PubMed          Journal:  J Epidemiol        ISSN: 0917-5040            Impact factor:   3.211


  7 in total

1.  CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD.

Authors:  Daryl M Okamura; Subramaniam Pennathur; Katie Pasichnyk; Jesús M López-Guisa; Sarah Collins; Maria Febbraio; Jay Heinecke; Allison A Eddy
Journal:  J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 10.121

2.  Serum cholesterol level and the rate of progression to renal failure.

Authors:  Masakazu Washio
Journal:  Clin Exp Nephrol       Date:  1998-12       Impact factor: 2.801

3.  Longitudinal lipid trends and adverse outcomes in patients with CKD: a 13-year observational cohort study.

Authors:  Ching-Wei Tsai; Han-Chun Huang; Hsiu-Yin Chiang; Chih-Wei Chung; Shih-Ni Chang; Pei-Lun Chu; Chin-Chi Kuo
Journal:  J Lipid Res       Date:  2019-01-14       Impact factor: 5.922

Review 4.  An update on 'progression promoters' in renal diseases.

Authors:  C O Alebiosu
Journal:  J Natl Med Assoc       Date:  2003-01       Impact factor: 1.798

Review 5.  Lipid levels and renal function decline in pre-dialysis patients.

Authors:  Moniek C M de Goeij; Joris I Rotmans; Xanthe Matthijssen; Dinanda J de Jager; Friedo W Dekker; Nynke Halbesma
Journal:  Nephron Extra       Date:  2015-02-04

Review 6.  Detrimental impact of hyperlipidemia on the peripheral nervous system: A novel target of medical epidemiological and fundamental research study.

Authors:  Song Wu; Xu Cao; Rongzhen He; Kun Xiong
Journal:  Neural Regen Res       Date:  2012-02-15       Impact factor: 5.135

Review 7.  Statins and Neuropathic Pain: A Narrative Review.

Authors:  Joseph V Pergolizzi; Peter Magnusson; Jo Ann LeQuang; Robin Razmi; Gianpietro Zampogna; Robert Taylor
Journal:  Pain Ther       Date:  2020-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.